Özet:

Purpose: Except for gastrointestinal stromal tumors, the gastrointestinal system's mesenchimal tumors are rare and most of them are beneficial. The aim of this study is to reveal the clinical and pathological characteristics of gastrointestinal stromal non-tumor mezenkimal tumors in the gastrointestinal system. Tools and Methods: Between 2008-2018, all gastrointestinal endoscopic and surgical resection materials were retrospective examined. Events that have been diagnosed with mezenkimal tumor outside of the gastrointestinal stromal tumor were included. The findings: Twenty-four lipomas, 14 inflammatory fibroid polyps, six leomyomas, four lymphanyomas, four hemangiomas, four schwannomas, two neuromas, two malign melanomas, a leomyosarcoma, a granular cell tumor and a Kaposi sarcoma were detected. The average age of the cases was 61 (29-87), the average tumor size was 1.5 cm (0.2-14) . Thirty-seven cases (58.7 percent) were female, 26 cases (41.3 percent) were male. These tumors have caused non-specific symptoms. In benign tumors, nuts or metastases have not been detected regardless of the pathological diagnosis after extinction. The result: Gastrointestinal stromal non-tumors of the gastrointestinal system are mostly small and beneficial tumors that can be seen in any age and often observed in women. The most common ones are lipomas and inflammatory fibroid polyps. Most stomach tumors cause dyspeptic complaints, and stomach tumors also cause stomach pain, nausea or vomiting. Also, some of the intestinal tumors lead to severe, even fatal clinical conditions such as acute and chronic bleeding, obstruction, perforation, volvulus or intussusseption. Excision is sufficient for the treatment of benign tumors, they do not show nickness or metastasis.